Cargando…

Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report

A recombinant von Willebrand factor (rVWF) was recently approved in the United States for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease (VWD). In contrast to plasma-derived VWF products available in the United States, rVWF does not contain factor VIII (FV...

Descripción completa

Detalles Bibliográficos
Autor principal: Brown, Racquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642339/
https://www.ncbi.nlm.nih.gov/pubmed/28379876
http://dx.doi.org/10.1097/MBC.0000000000000632

Ejemplares similares